Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing • Market size and forecast PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Natural tissue scaffolds • Synthetic tissue scaffolds • Market opportunity by product PART 08: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Musculoskeletal • Dermatological • Cardiovascular • Others PART 09: CUSTOMER LANDSCAPE PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Tissue scaffolds market in Americas • Tissue scaffolds market in EMEA • Tissue scaffolds market in APAC • Key leading countries • Market opportunity by region PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Growing M&A and strategic collaborations • Increasing technological advances PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bioventus • Integra Lifesciences • MiMedx Group • Organogenesis • RTI Surgical • Smith & Nephew • Other prominent vendors PART 16: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Parent market Exhibit 02: Global regenerative medicine market: Segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global tissue scaffolds market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global tissue scaffolds market – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Global tissue scaffolds market – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global natural tissue scaffolds market – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Global natural tissue scaffolds market – Year over year growth 2018-2022 (%) Exhibit 22: Global synthetic tissue scaffolds market – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Global synthetic tissue scaffolds market – Year over year growth 2018-2022 (%) Exhibit 24: Market opportunity by product Exhibit 25: Tissue scaffold market by application – Market share 2017-2022 (%) Exhibit 26: Customer landscape Exhibit 27: Global tissue scaffolds market – Market share by region 2017-2022 (%) Exhibit 28: Regional comparison Exhibit 29: Tissue scaffolds market in Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 30: Tissue scaffolds market in Americas – Year over year growth 2018-2022 (%) Exhibit 31: Top two countries in Americas Exhibit 32: Tissue scaffolds market in EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 33: Tissue scaffolds market in EMEA – Year over year growth 2018-2022 (%) Exhibit 34: Top two countries in EMEA Exhibit 35: Tissue scaffolds market in APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 36: Tissue scaffolds market in APAC – Year over year growth 2018-2022 (%) Exhibit 37: Top two countries in APAC Exhibit 38: Key leading countries Exhibit 39: Market opportunity by geography Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017 Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Bioventus: Overview Exhibit 47: Bioventus: Business segments Exhibit 48: Bioventus: Organizational developments Exhibit 49: Bioventus: Geographic focus Exhibit 50: Bioventus: Segment focus Exhibit 51: Bioventus: Key offerings Exhibit 52: Bioventus: Key customers Exhibit 53: Integra LifeSciences: Overview Exhibit 54: Integra LifeSciences: Business segments Exhibit 55: Integra LifeSciences: Organizational developments Exhibit 56: Integra LifeSciences: Geographic focus Exhibit 57: Integra LifeSciences: Segment focus Exhibit 58: Integra LifeSciences: Key offerings Exhibit 59: Integra LifeSciences: Key customers Exhibit 60: MiMedx Group: Overview Exhibit 61: MiMedx Group: Business segments Exhibit 62: MiMedx Group: Organizational developments Exhibit 63: MiMedx Group: Geographic focus Exhibit 64: MidMedx Group: Segment focus Exhibit 65: MidMedx Group: Key offerings Exhibit 66: MiMedx Group: Key customers Exhibit 67: Organogenesis: Overview Exhibit 68: Organogenesis: Business segments Exhibit 69: Organogenesis: Organizational developments Exhibit 70: Organogenesis: Geographic focus Exhibit 71: Organogenesis: Segment focus Exhibit 72: Organogenesis: Key offerings Exhibit 73: Organogenesis: Key customers Exhibit 74: RTI Surgical: Overview Exhibit 75: RTI Surgical: Business segments Exhibit 76: RTI Surgical: Organizational developments Exhibit 77: RTI Surgical: Geographic focus Exhibit 78: RTI Surgical: Segment focus Exhibit 79: RTI Surgical: Key offerings Exhibit 80: RTI Surgical: Key customers Exhibit 81: Smith & Nephew: Overview Exhibit 82: Smith & Nephew: Business segments Exhibit 83: Smith & Nephew: Organizational developments Exhibit 84: Smith & Nephew: Geographic focus Exhibit 85: Smith & Nephew: Segment focus Exhibit 86: Smith & Nephew: Key offerings Exhibit 87: Smith & Nephew: Key customers

Bioventus, Integra Lifesciences, MiMedx Group, Organogenesis, RTI Surgical, and Smith & Nephew